UAE providers face $100bn Middle East capex test in 2026

Middle East strategic capital expenditure is expected to exceed $100bn annually in 2026, according to Arabian Business, citing Grand View Research.

For UAE healthcare CEOs, CFOs and CIOs, the point is capital discipline: hospitals, diagnostic chains and health-tech vendors will compete with energy, cloud, AI and manufacturing projects for funding in 2026.

Why the $100bn figure matters

The $100bn figure equals about AED 367bn at the UAE dirham's dollar peg. Healthcare will compete for a share of that pool, which raises the bar for every provider asking investors to fund digital health, AI diagnostics or specialty capacity in 2026.

Dubai Health Authority (DHA) said Dubai had about 5,800 licensed healthcare facilities in 2025, up from 5,340 in 2024, or more than 8% growth. DHA also reported 69,400 private-sector healthcare professionals in 2025, up from 64,100 in 2024.

• 5,800 licensed Dubai healthcare facilities in 2025, according to DHA.
• 10.41m medical records on NABIDH by the end of June 2025, according to DHA.
• AED 13bn for the Abu Dhabi Government Digital Strategy 2025-2027, according to the Abu Dhabi Media Office.
• 200+ AI solutions planned across Abu Dhabi government services under that strategy.

DHA said its NABIDH platform held more than 10.41m medical records by the end of June 2025, with 1,888 licensed facilities and 91 electronic medical record systems connected. For CIOs, interoperability now belongs in every capital request and vendor scorecard.

What UAE executives should test

The investment case now rests on evidence. UAE operators seeking capital in 2026 need to show how each dirham of capex produces reimbursable activity, faster clinical throughput or lower administrative cost.

CEOs should test specialty care, diagnostics, ambulatory surgery and chronic disease platforms for referral capture and network fit. CFOs should model technology spend against payer pressure, claim rejection rates and staffing cost. CIOs should rank interoperable EHR, cybersecurity, AI governance and revenue-cycle systems ahead of discretionary patient apps.

Department of Health - Abu Dhabi (DoH) signed a memorandum with Microsoft on 21 April 2025 to co-develop an AI-powered population health intelligence framework. The Abu Dhabi Media Office said the emirate's digital strategy will deploy AED 13bn from 2025 to 2027 and implement more than 200 AI solutions across government services.

For medical directors, the procurement issue is governance. Any AI diagnostic or population-health product bought in 2026 will need clinical validation, audit trails, liability rules and patient-data controls before clinicians, insurers and regulators trust it.

The regulatory split operators cannot ignore

The UAE remains a multi-regulator market. DHA oversees Dubai, DoH regulates Abu Dhabi and Al Ain, and the Ministry of Health and Prevention (MOHAP) regulates much of the Northern Emirates, so a provider expanding across 3 jurisdictions needs separate licensing, data, insurance and clinical governance plans.

This matters for acquisitions in 2026. A clinic group with 20 branches may look strong on revenue, but buyers should diligence health information systems with the same care used for leases, doctor contracts and receivables.

The number to remember is $100bn. If that regional capex reaches healthcare through digital health, AI diagnostics and specialty platforms, UAE providers with clean data, regulator-ready systems and service-line economics will enter the stronger funding talks in 2026.